These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20298220)

  • 1. Metallothioneins and copper metabolism are candidate therapeutic targets in Huntington's disease.
    Hands SL; Mason R; Sajjad MU; Giorgini F; Wyttenbach A
    Biochem Soc Trans; 2010 Apr; 38(2):552-8. PubMed ID: 20298220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A series of N-terminal epitope tagged Hdh knock-in alleles expressing normal and mutant huntingtin: their application to understanding the effect of increasing the length of normal Huntingtin's polyglutamine stretch on CAG140 mouse model pathogenesis.
    Zheng S; Ghitani N; Blackburn JS; Liu JP; Zeitlin SO
    Mol Brain; 2012 Aug; 5():28. PubMed ID: 22892315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Huntington disease arises from a combinatory toxicity of polyglutamine and copper binding.
    Xiao G; Fan Q; Wang X; Zhou B
    Proc Natl Acad Sci U S A; 2013 Sep; 110(37):14995-5000. PubMed ID: 23980182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutant huntingtin promotes the fibrillogenesis of wild-type huntingtin: a potential mechanism for loss of huntingtin function in Huntington's disease.
    Busch A; Engemann S; Lurz R; Okazawa H; Lehrach H; Wanker EE
    J Biol Chem; 2003 Oct; 278(42):41452-61. PubMed ID: 12888569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of copper ion mediated Huntington's disease progression.
    Fox JH; Kama JA; Lieberman G; Chopra R; Dorsey K; Chopra V; Volitakis I; Cherny RA; Bush AI; Hersch S
    PLoS One; 2007 Mar; 2(3):e334. PubMed ID: 17396163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models.
    Ehrnhoefer DE; Duennwald M; Markovic P; Wacker JL; Engemann S; Roark M; Legleiter J; Marsh JL; Thompson LM; Lindquist S; Muchowski PJ; Wanker EE
    Hum Mol Genet; 2006 Sep; 15(18):2743-51. PubMed ID: 16893904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cytomegalovirus UL97 kinase prevents the deposition of mutant protein aggregates in cellular models of Huntington's disease and ataxia.
    Tower C; Fu L; Gill R; Prichard M; Lesort M; Sztul E
    Neurobiol Dis; 2011 Jan; 41(1):11-22. PubMed ID: 20732421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of endoplasmic reticulum stress counteracts neuronal cell death and protein aggregation caused by N-terminal mutant huntingtin proteins.
    Reijonen S; Putkonen N; Nørremølle A; Lindholm D; Korhonen L
    Exp Cell Res; 2008 Mar; 314(5):950-60. PubMed ID: 18255062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing formation of toxic N-terminal huntingtin fragments through antisense oligonucleotide-mediated protein modification.
    Evers MM; Tran HD; Zalachoras I; Meijer OC; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; van Roon-Mom WM
    Nucleic Acid Ther; 2014 Feb; 24(1):4-12. PubMed ID: 24380395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of calcineurin by FK506 protects against polyglutamine-huntingtin toxicity through an increase of huntingtin phosphorylation at S421.
    Pardo R; Colin E; Régulier E; Aebischer P; Déglon N; Humbert S; Saudou F
    J Neurosci; 2006 Feb; 26(5):1635-45. PubMed ID: 16452687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD).
    Ratovitski T; Arbez N; Stewart JC; Chighladze E; Ross CA
    Cell Cycle; 2015; 14(11):1716-29. PubMed ID: 25927346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A huntingtin peptide inhibits polyQ-huntingtin associated defects.
    Arribat Y; Bonneaud N; Talmat-Amar Y; Layalle S; Parmentier ML; Maschat F
    PLoS One; 2013; 8(7):e68775. PubMed ID: 23861941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arfaptin 2 regulates the aggregation of mutant huntingtin protein.
    Peters PJ; Ning K; Palacios F; Boshans RL; Kazantsev A; Thompson LM; Woodman B; Bates GP; D'Souza-Schorey C
    Nat Cell Biol; 2002 Mar; 4(3):240-5. PubMed ID: 11854752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased cAMP response element-mediated transcription: an early event in exon 1 and full-length cell models of Huntington's disease that contributes to polyglutamine pathogenesis.
    Sugars KL; Brown R; Cook LJ; Swartz J; Rubinsztein DC
    J Biol Chem; 2004 Feb; 279(6):4988-99. PubMed ID: 14627700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Huntington's disease does not appear to increase the risk of diabetes mellitus.
    Boesgaard TW; Nielsen TT; Josefsen K; Hansen T; Jørgensen T; Pedersen O; Nørremølle A; Nielsen JE; Hasholt L
    J Neuroendocrinol; 2009 Sep; 21(9):770-6. PubMed ID: 19602103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-scale RNA interference screening in mammalian cells identifies novel regulators of mutant huntingtin aggregation.
    Yamanaka T; Wong HK; Tosaki A; Bauer PO; Wada K; Kurosawa M; Shimogori T; Hattori N; Nukina N
    PLoS One; 2014; 9(4):e93891. PubMed ID: 24705917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cdk5 phosphorylation of huntingtin reduces its cleavage by caspases: implications for mutant huntingtin toxicity.
    Luo S; Vacher C; Davies JE; Rubinsztein DC
    J Cell Biol; 2005 May; 169(4):647-56. PubMed ID: 15911879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α-Synuclein accumulates in huntingtin inclusions but forms independent filaments and its deficiency attenuates early phenotype in a mouse model of Huntington's disease.
    Tomás-Zapico C; Díez-Zaera M; Ferrer I; Gómez-Ramos P; Morán MA; Miras-Portugal MT; Díaz-Hernández M; Lucas JJ
    Hum Mol Genet; 2012 Feb; 21(3):495-510. PubMed ID: 22045698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins.
    Huang CC; Faber PW; Persichetti F; Mittal V; Vonsattel JP; MacDonald ME; Gusella JF
    Somat Cell Mol Genet; 1998 Jul; 24(4):217-33. PubMed ID: 10410676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A structure-based analysis of huntingtin mutant polyglutamine aggregation and toxicity: evidence for a compact beta-sheet structure.
    Poirier MA; Jiang H; Ross CA
    Hum Mol Genet; 2005 Mar; 14(6):765-74. PubMed ID: 15689354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.